Biotech News
Adlai Nortye Reports Full Year 2024 Financial Results and Business Updates
ir.adlainortye.com2026-05-06 15:28 EST
SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, April. 30, 2025 -- Adlai Nortye Ltd. (NASDAQ: ANL) (the "Company" or "Adlai Nortye"), a global clinical-stage biotechnology company focused on the development of innovative targeted and immune-modulating cancer therapies, today announced its